E-MAIL: your-email@mail.com
E-MAIL: your-email@mail.com
Abbott’s next-generation Oncodetect MRD test analyses tumour-specific DNA markers in blood samples to help detect residual disease and assess cancer recurrence risk during and after treatment.
imphoenix82
Abbott’s Cologuard Plus, developed in collaboration with Mayo Clinic, analyses multiple DNA markers and blood in the stool associated with colorectal cancer and advanced precancerous lesions.
imphoenix82
Abbott’s Libre Duo 10 Day provides real-time glucose readings for daily diabetes management while continuously monitoring ketone levels in the background.
imphoenix82HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 9354115542
HealthXploreIndia @2026. All Rights Reserved.
